Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × NET × 90 days × Clear all

Phase

Phase 2 24 Phase 3 9 Phase 1 9 Phase NA 5 Phase 1/2 3 Phase 4 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 31 Thoracic 21 Head & Neck 13 Breast 12 Genitourinary 11 Other hematologic neoplasm 9 Lymphoid 9 Gynecologic 9 Sarcoma 7 Tumor-Agnostic 6 Plasma cell 5 Myeloid 5 CNS 5 Other solid neoplasm 3 Endocrine 3 Dermatologic 3 Classical hematology 2 Other 1 NET 1

Conditions

Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Adenoma, Islet Cell 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06943755 2026-02-27

STELLAR-311

Exelixis

Phase 2/3 Recruiting

Adenoma, Islet Cell, Neoplasm Metastasis, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡